Impact of Perceived Cardiovascular Risk on Cardiovascular Disease Prevention Behaviors in People With and Without HIV Infection

被引:7
|
作者
Webel, Allison [1 ]
Davey, Christine Horvat [1 ]
Schexnayder, Julie [1 ]
Currie, Jackson [2 ]
Al Battashi, Hamed [1 ]
Chang, Julia [1 ]
Longenecker, Chris T. [1 ]
机构
[1] Case Western Reserve Univ, 10900 Euclid Ave, Cleveland, OH 44016 USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
关键词
HIV; cardiovascular disease; medication adherence; physical activity; diet; PHYSICAL-ACTIVITY; MIXED METHODS; HEALTH; PERSPECTIVES; STATEMENT; KNOWLEDGE; EXERCISE;
D O I
10.1097/QAI.0000000000002290
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: People living with HIV (PLHIV) are at elevated risk of developing atherosclerotic cardiovascular disease (ASCVD). PLHIV do not engage in recommended levels of ASCVD prevention behaviors, perhaps due to a reduced perception of risk for ASCVD. We examined how HIV status influences knowledge, beliefs, and perception of risk for ASCVD and ASCVD prevention behaviors. Methods and Results: We conducted a mixed-methods study of 191 PLHIV and demographically similar HIV-uninfected adults. Participants completed self-reported surveys on CVD risk perceptions, adherence to CVD medication (aspirin, antihypertensives, and lipid-lowering medication) and 3 dietary intake interviews. All wore an accelerometer to measure physical activity. A subset of PLHIV (n = 38) also completed qualitative focus groups to further examine the influence of HIV on knowledge, perception of risk for ASCVD, and behavior. Participants: They were approximately 54 (+/- 10) years, mostly men (n = 111; 58%), and African American (n = 151, 83%) with an average 10-year risk of an ASCVD event of 10.4 (+/- 8.2)%. PLHIV were less likely to engage in physical activity (44% vs 65%, P < 0.05), and HIV status was associated with 43 fewer minutes of physical activity per week (P = 0.004). Adherence to ASCVD medications was better among PLHIV (P < 0.001). Diet composition was similar between groups (P > 0.05). HIV status did not influence ASCVD risk perceptions (P > 0.05) and modestly influenced physical activity and smoking. Conclusions: Although perceptions of ASCVD risk modestly influence some behaviors, additional barriers and insufficient cues to action result in suboptimal physical activity, dietary intake, and smoking rates. However, PLHIV have high adherence to ASCVD medications, which can be harnessed to reduce their high burden of ASCVD.
引用
收藏
页码:513 / 521
页数:9
相关论文
共 50 条
  • [31] HIV infection and cardiovascular disease
    Hemkens, Lars G.
    Bucher, Heiner C.
    EUROPEAN HEART JOURNAL, 2014, 35 (21) : 1373 - U24
  • [32] Managing cardiovascular risk in patients with HIV infection
    Stein, JH
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (02) : 115 - 123
  • [33] Influence of HIV infection on highest cardiovascular risk
    Wegrzynowicz, Agnieszka
    Skowyra, Artur
    Kazmierczak, Marta
    Mikula, Tomasz
    Wiercinska-Drapalo, Alicja
    HIV & AIDS REVIEW, 2009, 8 (03): : 21 - 23
  • [34] Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy
    Hugo Ribeiro Zanetti
    Edmar Lacerda Mendes
    Antonio Carlos Palandri Chagas
    Maria Odila Gomes Douglas
    Leandro Teixeira Paranhos Lopes
    Leonardo Roever
    Alexandre Gonçalves
    Elmiro Santos Resende
    Current Atherosclerosis Reports, 2018, 20
  • [35] The efficacy and feasibility of lifestyle interventions on modifiable cardiovascular disease risk factors among people with inflammatory bowel disease
    Yap, J. M.
    Wall, C. L.
    Schultz, M.
    Meredith-Jones, K.
    Osborne, H.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2025,
  • [36] The importance of healthy lifestyle behaviors in the prevention of cardiovascular disease
    Kaminsky, Leonard A.
    German, Charles
    Imboden, Mary
    Ozemek, Cemal
    Peterman, James E.
    Brubaker, Peter H.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2022, 70 : 8 - 15
  • [37] Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy
    Zanetti, Hugo Ribeiro
    Mendes, Edmar Lacerda
    Palandri Chagas, Antonio Carlos
    Gomes Douglas, Maria Odila
    Paranhos Lopes, Leandro Teixeira
    Roever, Leonardo
    Goncalves, Alexandre
    Resende, Elmiro Santos
    CURRENT ATHEROSCLEROSIS REPORTS, 2018, 20 (06)
  • [38] Reducing the risk of atherosclerotic cardiovascular disease in people with hemophilia: the importance of primary prevention
    Dix, Caroline
    Dolan, Gerry
    Hunt, Beverley J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (05) : 1304 - 1312
  • [39] Cardiovascular Disease Risk Factor Control in People With and Without Human Immunodeficiency Virus
    Silverberg, Michael J.
    Levine, Tory M.
    Lea, Alexandra N.
    Williams, Andrew E.
    Alexeeff, Stacey E.
    Bryant, Kendall
    Cavassini, Matthias
    Flamm, Jason A.
    Hare, C. Bradley
    Ingle, Suzanne M.
    Justice, Amy C.
    Lam, Jennifer O.
    Sterling, Stacy A.
    Horberg, Michael A.
    Satre, Derek D.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (05) : 1264 - 1271
  • [40] Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV
    van Zoest, Rosan A.
    Law, Matthew
    Sabin, Caroline A.
    Vaartjes, Ilonca
    Van der Valk, Marc
    Arends, Joop E.
    Reiss, Peter
    Wit, Ferdinand W.
    Geerlings, S. E.
    Godfried, M. H.
    Goorhuis, A.
    Hovius, J. W.
    Kuijpers, T. W.
    Nellen, F. J. B.
    van der Poll, D. T.
    Prins, J. M.
    van Vugt, H. J. M.
    Wiersinga, W. J.
    van Duinen, M.
    van Eden, J.
    van Hes, A. M. H.
    Pijnappel, F. J. J.
    Weijsenfeld, A. M.
    Jurriaans, S.
    Back, N. K. T.
    Zaaijer, H. L.
    Berkhout, B.
    Cornelissen, M. T. E.
    Schinkel, C. J.
    Wolthers, K. C.
    Peters, E. J. G.
    van Agtmael, M. A.
    Bomers, M.
    Heitmuller, M.
    Laan, L. M.
    Ang, C. W.
    van Houdt, R.
    Pettersson, A. M.
    Vandenbroucke-Grauls, C. M. J. E.
    van den Berge, M.
    Stegeman, A.
    Baas, S.
    de Looff, L. Hage
    Wintermans, B.
    Veenemans, J.
    Pronk, M. J. H.
    Ammerlaan, H. S. M.
    de Munnik, E. S.
    Jansz, A. R.
    Tjhie, J.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2019, 81 (05) : 562 - 571